The global prevalence of PNH is as high as 15.9 individuals per 1 million people. The annual global incidence of PNH is around 5 to 6 individuals per 1 million people. 5,6 In the United States, ...

Rare Disease Advisor, a trusted source of medical news and feature content for healthcare providers, offers clinicians insight into the latest research to inform clinical practice and improve patient ...

Test Your Knowledge About the Signs and Symptoms of FNAIT Test Your Knowledge About the Epidemiology of FNAIT Test Your Knowledge About the Diagnosis of FNAIT Rare Disease Advisor, a trusted source of ...

Test Your Knowledge About a Study on Denosumab for PBC Test Your Knowledge About Elafibranor for the Treatment of PBC Rare Disease Advisor, a trusted source of medical news and feature content for ...

Single-gene testing targets the TK2 gene and typically includes sequence analysis and gene-targeted deletion/duplication analysis under specific circumstances. 1 Sequence analysis is performed first ...

Overall, the life expectancy of patients with SCD is lower than that of persons without SCD. 1 However, life expectancy varies depending on the type of disease, treatments administered, and ...

Rare Disease Advisor, a trusted source of medical news and feature content for healthcare providers, offers clinicians insight into the latest research to inform clinical practice and improve patient ...

Chronic inflammatory demyelinating polyneuropathy (CIDP) is a rare acquired autoimmune neurological disorder in which both T-cell-mediated and humoral immune mechanisms target healthy myelinated ...

In 2020, women accounted for 75% of cases in the 26-to-35-year age group, but closer to 50% among those aged 65 years or older. Researchers have identified critical disparities in the diagnosis of and ...

Biochemical response rates were sustained through week 182 in patients with PBC treated with elafibranor, and the proportion of patients with normal alkaline phosphatase levels remained consistent.

Sharon Hesterlee, PhD, who previously served as chief research officer at the MDA, has been named interim president and CEO. Donald S. Wood, PhD, has retired from the Muscular Dystrophy Association ...

Test Your Knowledge About Panzyga for the Treatment of CIDP Test Your Knowledge About Life Expectancy for CIDP Test Your Knowledge About Clinical Features of CIDP ...